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Background: Little is known about the relationship between hemoglobin concentrations, functional status and
health related quality of life (HRQL) in chronic obstructive pulmonary disease (COPD). Our aim was to investigate
the prevalence of anemia and the association of hemoglobin with shortness of breath, exercise capacity, muscle
strength and HRQL, in COPD patients.
Methods: A total of 105 COPD patients (77 males, 71.6 ± 9.2 years) were studied. Patients were classified as anemic
and non anemic using the WHO criteria. We used the Medical Research Council Dyspnoea scale (MRCs) to measure
shortness of breath. Exercise capacity was assessed using the six minute walking distance (6MWD) and the peak of
VO2 during the maximal cycle ergometer test (VO2max). We used the Quadriceps and Handgrip strength assessment
to determine muscle strength. The Saint George Respiratory Questionnaire was used to investigate HRQL. The
physiological/functional characteristics of the two groups were compared. Regression models adjusting for
confounders examined the independent association of anemia and of hemoglobin levels with clinical and
functional outcomes.
Results: Anemic patients (12.3%) showed a significantly higher MRCs, a lower 6MWD, VO2max, and a worse
quality of life. On the contrary, there was no difference in muscle strength between the two groups. In the
regression models, hemoglobin was independently associated with reduced exercise capacity and HRQL.
Conclusions: Anemia in COPD was a risk factor for poorer exercise capacity and quality of life, and these
outcomes were linearly associated with hemoglobin. Our results should stimulate further research into
exploring whether increasing hemoglobin has a beneficial effect on the outcomes in COPD.
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Chronic obstructive pulmonary disease (COPD), a highly
prevalent condition associated with increased morbidity
and mortality, is basically characterized by the presence
of expiratory flow limitation that is not fully reversible
[1]. Great importance has recently been given to the role
of inflammation in this disease, which could explain
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unless otherwise stated.such as weight loss, muscle atrophy and the consequent
reduction in exercise capacity [2-4]. Some authors [5]
consider that anemia is also caused by the inflammatory
process.
Anemia is frequently concomitant with many chronic
diseases and is associated with increased morbidity and
mortality [6-14]. Anemia is also characterized by a feel-
ing of weakness and fatigue, and it has been suggested
that it may contribute to dyspnoea and exercise limita-
tion in patients with chronic diseases and also when this
condition affects the elderly [15,16].
Several previous studies have evaluated the preva-
lence of anemia in chronic obstructive pulmonary diseaseThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Ferrari et al. BMC Pulmonary Medicine  (2015) 15:58 Page 2 of 8[5,17,18]. On the contrary, scarce research has focused on
examining the relationship between hemoglobin concen-
trations, dyspnoea, and exercise capacity [5,17] in COPD,
and no study has been performed on its correlation with
muscle strength. It is worth noting that only one investiga-
tion has been carried out on the relationship between
hemoglobin levels and HRQL, which is an important clin-
ical outcome in patients with chronic lung disease [19].
The aims of the study were to assess in stable COPD
patients: 1) the distribution of hemoglobin values, the
prevalence of anemia and their relationship with short-
ness of breath, exercise capacity and muscle strength; 2)
the association between hemoglobin levels, anemia and
HRQL.
Methods
The present study was a retrospective analysis of the
data collected in the medical records of the COPD pa-
tients attending our outpatient clinic from January
2013 to December 2013. The review board of the De-
partment of Medicine of Verona University approved
the access to patient records and patient confidentiality
was maintained.
The patients were included in the study if they satisfied
the following criteria: a diagnosis of COPD [20] and a
stable clinical condition, which meant that they had re-
ceived continuous treatment and had had no exacerbation
during the previous two months. The exclusion criteria
were a severe cardiovascular disease, malignant diseases,
systemic rheumatologic or connective tissue disorders,
chronic renal failure. Additional exclusion criteria were
the use of oral corticosteroid and long term oxygen
therapy, and the inability to perform the exercise tests.
Clinical assessment and anthropometric measurements
Smoking habits and the presence of comorbid conditions
was determined by using self-reported history, medical
examination data and medical records information. Scores
on the Charlson comorbidity index (CCI), a method for
classifying comorbid conditions, were calculated [21] from
these data. Functional dyspnoea was measured using the
Medical Research Council dyspnoea scale (MRCs) [22].
BODE index, a composite index of COPD severity, was
also calculated [23]. In order to evaluate Health Related
Quality of Life (HRQL), patients filled in the St. George’s
Respiratory Questionnaire (SGRQ). Body mass index
(BMI) was obtained by dividing body weight by height
squared (kg/m2).
On the same day of the clinical assessment, each pa-
tient underwent a peripheral venous blood sampling, a
pulmonary function testing, an evaluation of muscle
strength and 6MWT. Exercise testing was performed
on a separate day, within a week from the beginning of
clinical assessment.Blood sample and analysis
All the patients underwent peripheral venous blood
sampling to determine haemoglobin (Hb) concentra-
tions (hematology autoanalyzer Advia 2120i, Simens
Healthcare, Milan) and C-reactive protein concentra-
tions (CRP) (immunoturbidimetric assay, Cobas 6000,
Roche Diagnostics, Milan). Anemia was defined by using
the WHO criteria, which meant that the Hb concentration
was below 12 g/dL in women and below 13 g/dL in men
[24]. Patients were categorized as polycythemic when they
presented Hb levels ≥ 17 g/dL and ≥15 g/dL in males and
females, respectively [5].
Pulmonary function test
Spirometry was done pre and post use of bronchodilator
(salbutamol 400mcg) and forced expiratory volume in 1-
second (FEV1), forced vital capacity (FVC), FEV1/FVC
were measured in accordance with ATS/ERS guidelines
[25] by using a Sensor Medics Spirometer (Jorba Linda,
Ca, USA). Predicted values were calculated according to
Quanier [26].
Muscle strength
Handgrip strength was measured in kg using a hydraulic
hand-held dynamometer (Saehan Corp., Masan, Korea).
The participants were asked to perform the task three
times with each hand. The average of the best results
obtained with each hand was used for the analysis. Iso-
metric knee extension strength (kg) was measured in
both legs with a dynamometer (Kern CH50K50, Kern
& Sohn, Balingen, Germany), which was applied with
a strap around the ankle, just proximal to the mal-
leolli. After one try out, the best of three measure-
ments was recorded on both sides. The average of the
best measurement obtained on each side was used in
the analysis.
Exercise testing
The 6-min walk distance (6MWD) was performed accord-
ing to the ATS statement [27]. Patients were instructed to
walk as far as possible for 6 minutes, stopping for a rest if
necessary. The total distance walked was measured to the
nearest meter and recorded.
All the subjects performed a maximal bicycle test until
exhaustion, according to the criteria of ATS on cardio-
pulmonary exercise testing [25]. The subjects cycled on
an electrically braked cycle ergometer (Corival 400,
Lode, Groningen, The Netherlands) at a pedalling rate of
60 rpm, breathing room air. After unloaded pedalling for
3 minutes, the workload was increased every minute by
5–20 W, until exhaustion. Exercise parameters and VO2
(L/min) were collected breath-by-breath and averaged
over 10-second intervals, using ZAN600 cardiopulmonary
measuring device (ZAN600 Ferraris, Germany).
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The between-group differences in baseline characteristics
of COPD, with and without anemia, were expressed as
mean ± sd values and these differences were calculated by
using a two-sided test for independent samples, or Chi-
squared statistic where appropriate. A p-value <0.05 was
considered statistically significant. Linear regression ana-
lysis controlling for age, sex, BMI, smoking habits, PCR
serum levels, FEV1, CCI, were used to evaluate the inde-
pendent association of anemia with dyspnoea (MRCs),
physical performance (6MWD, VO2max, Handgrip and
Quadriceps strength) and quality of life (SGRQ). In similar
models, the association of hemoglobin concentrations
with the same outcomes was evaluated. The data analysis
was performed using the Statistical Package for Social
Science, version 20.0 (SPSS, Chicago, IL).
Results
Out of the 105 patients included in the study, 13 (12.3%)
had anemia, while polycythemia was recorded in 7 (6.7%)
patients. The anemia was mild in most cases, with a mean
hemoglobin value of 11.9 ± 0.5 g/dL. Table 1 shows the
characteristics of the patients in our series and the differ-
ences in clinical data between the groups of cases with or
without anemia. Patients in the anemia group had more
severe COPD in terms of FEV1 (p < 0.0001), either when
expressed in absolute or in percent of predicted values.
Also the BODE index was higher in anemic subjects
(p = 0.001). The mean CRP plasma concentrations were
higher in anemic patients with respect to those without
anemia, although the difference was not statisticallyTable 1 Clinical characteristics of COPD patients divided into
Variable Total
Subjects ( n) 105
Male sex (n(%)) 77 (73)
Age (yrs) 71.6 ± 9.2
Weight (kg) 74.6 ± 14.1
Height (cm) 164.1 ± 7.8
BMI 27.7 ± 4.6
Smoking habits (Pack/year) 39.0 ± 30.1
VC (l) 2.8 ± 0.8
VC %predicted 91.0 ± 22.1
FEV1 (l) 1.3 ± 0.6
FEV1 % predicted 55.7 ± 20.2
BODE Index 2.9 ± 2.3
CCI 2.5 ± 1.5
Hemoglobin (g/dL) 14.2 ± 1.3
CRP (mg/L) 13.4 ± 13.8
The data are presented as mean ± sd, unless otherwise stated. BMI: Body Mass Inde
mass index, airflow Obstruction, Dyspnoea, Exercise capacity, CCI: Charlson Comorb
* = calculated using 2 site unpaired t-tests.significant, which was probably due to the high stand-
ard deviation of our data. There were no differences in
age, sex, BMI, smoking history and CCI between pa-
tients with or without anemia. A significant negative
relationship was found between CRP serum concentra-
tions and hemoglobin levels (r = −0.349, p < 0.0001,
data not shown) in a bivariate analysis.
Performance and strength outcomes, dyspnoea, and
quality of life according to the presence or absence of
anemia, are reported in Table 2. Mean MRCs values
were significantly higher (2.8 ± 1.1 versus 1.6 ± 1.3; p =
0.002), mean 6MWD was significantly shorter (267.9 ±
86.7 versus 373.0 ± 122.8 m; p = 0.001), and VO2max
results lower (0.9 ± 0.2 versus 1.2 ± 0.4 L/min; p = 0.011)
in anemic compared with non anemic patients. On the
contrary, the mean values of handgrip (28.7 ± 6.5 versus
29.8 ± 8.5 kg) and quadriceps strength (21.3 ± 5.1 versus
21.0 ± 7.7 kg) were similar in the two groups. Quality of
life, measured by using the SGRQ questionnaire, was
significantly worse in subjects with anemia, as far as ei-
ther total score or symptoms, activity or impact scores
were concerned.
When MRCs, 6MWD, VO2max and SGRQ scores
were evaluated as a function of hemoglobin ranges, a
linear relationship between declining hemoglobin on
one hand, and increasing dyspnoea, worsening of exercise
capacity and of quality of life on the other hand, was found
(Figures 1 and 2). In regression models controlling for age,
sex, BMI, FEV1, smoking habits (packyears), CCI and
CRP, Hb levels remained an independent predictor
of 6MWD (Table 3, Figure 3-panel A) and VO2maxtwo groups on the basis of the presence of anemia
Anemic Non anemic p-value*
13 (12.4) 92 (87.6)
11 (85) 66 (71.7) 0.326
72.8 ± 8.7 71.4 ± 9.3 0.606
72.4 ± 14.2 74.9 ± 14.1 0.554
161.1 ± 7.0 164.6 ± 7.9 0.118
27.8 ± 4.4 27.7 ± 4.6 0.968
49.3 ± 38.8 37.7 ± 28.8 0.358
2.6 ± 0.6 2.8 ± 0.8 0.361
85.3 ± 19.9 91.9 ± 22.4 0.294
0.9 ± 0.2 1.4 ± 0.6 <0.0001
42.8 ± 9.7 57.6 ± 20.7 <0.0001
5.0 ± 2.0 2.7 ± 2.2 0.001
2.5 ± 2.0 2.5 ± 1.4 0.992
11.9 ± 0.5 14.5 ± 1.1 <0.0001
18.3 ± 14 12.8 ± 13.7 0.200
x; FEV1: Forced expiratory volume in 1 second; VC: Vital Capacity; BODE: Body
idity Index; CRP: C-reactive Protein.
Table 2 Exercise capacity, muscular strength, degree of dyspnoea and quality of life in COPD patients, divided
according to the presence of anemia
Total Anemic Non anemic p-value*
6MWD (m) 360.0 ± 123.6 267.9 ± 86.7 373.0 ± 122.8 0.001
VO2max (l/min) 1.2 ± 0.4 0.9 ± 0.2 1.2 ± 0.4 0.011
Handgrip (Kg) 29.7 ± 8.3 28.7 ± 6.5 29.8 ± 8.5 0.572
Quadriceps Strength (Kg) 21.1 ± 7.4 21.3 ± 5.1 21.0 ± 7.7 0.853
MRC Dyspnoea scale 1.8 ± 1.4 2.8 ± 1.1 1.6 ± 1.3 0.002
SGRQ Symptoms 47.3 ± 23.3 63.6 ± 20.0 45.3 ± 22.9 0.020
SGRQ Activity 54.6 ± 24.3 78.6 ± 15.9 51.6 ± 23.5 <0.0001
SGRQ Impact 32.0 ± 21.2 53.4 ± 25.7 29.4 ± 19.1 0.016
SGRQ Total 41.4 ± 20.2 62.8 ± 20.9 38.7 ± 18.6 0.005
The data are presented as mean ± sd; 6MWD: six minutes walking distance; VO2max: maximal oxygen consumption; MRC: Medical Research Council; SGRQ: St
George Respiratory Questionnaire.
* = calculated using 2 site unpaired t-tests.
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strength and handgrip (data not shown). Furthermore,
higher hemoglobin levels were correlated to a higher
quality of life (Table 4, Figure 3-panel B).
Discussion
The prevalence of anemia in this study (12.3%) is com-
parable to that found by John et al. (13%) [28] in sub-
jects with COPD, and to that reported by Penninx et al.
in Italy, in non-institutionalized elderly subjects (11.3%)
[16]. The agreement with the data reported by Penninx
et al. [16] indicates that the frequency of anemia in
COPD is not greater than what was found in the gen-
eral population. On the contrary, the prevalence we
found in our study is less than that observed by Cote
et al. in a cohort of patients with stable COPD (17%)
[5] and by Halpern et al. (21%) [18]. The criteria used
to identify anemia by Cote et al.( <13 g/dL independ-
ently from gender ) [5], and the difference in the popu-
lation studied (subjects with COPD from the US
Medicare Claims Database, in the study carried out by
Halpern et al. [18]) can justify the discrepancy of the
results. Only Casanova et al. [29] reported a prevalenceFigure 1 Hemoglobin and exercise capacity. Relationship between hemog
oxygen consumption (VO2max) and Medical Research Council dysnoea scalof anemia that was lower (6.2%) than the one found in
the present study.
The mechanism of the development of anemia in pa-
tients with COPD may be similar to that of other chronic
diseases, in which the involvement of inflammatory re-
sponse mediators in the pathogenesis of anemia has been
demonstrated [28]. Our data are in agreement with this
hypothesis, since CRP levels in anemic patients tended to
be higher than in non anemic ones, and serum concentra-
tions of CRP were inversely related to hemoglobin levels
(r = −0349, p <0.0001). Anemic patients in the present
study had more severe airflow obstruction in comparison
to non-anemic patients, and they also had a significantly
higher BODE index score, whereas we found no differ-
ences in CCI in our patient series, which is different from
other authors [5].
It is of interest to note that the anemic subjects in our
study presented a reduction in exercise capacity, expressed
as 6MWD and VO2max, a greater degree of dyspnoea and
a worse HRQL compared with non anemic patients. On
the contrary, muscle strength indices were similar in both
groups. Anemia has been repeatedly associated with re-
duced exercise capacity in patients with chronic diseaseslobin (Hb) level and six Minutes Walking Distance (6MWD), maximal
e (MRCs).
Figure 2 Hemoglobin and quality of life. Relationship between
hemoglobin (Hb) level and the St George Respiratory Questionnaire
(SGRQ) total ( ), activity ( ), symptoms ( ) and impact ( ) scores.
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to a reduction of VO2max [17] and of distance walked at
6MWD [5] in patients with COPD. The present study
confirms that anemia is a determinant of exercise capacity,
regardless of the degree of airway obstruction. The mecha-
nisms underlying the relationship between hemoglobin
and exercise capacity are complex, even if the release of
oxygen to the mitochondria probably plays a crucial role.
When the content of arterial O2 is low, the gradient of
diffusion of the gas from the blood to the mitochondria
decreases rapidly, producing an early anaerobic metabolism
[36], with consequent stimulus to ventilation. Since COPD
patients have a reduced respiratory reserve, the increase in
demand for ventilation may produce dyspnoea and conse-
quently an increase in the MRCs, and a decrease in exercise
capacity. It has been demonstrated that the degree of
inflammation predicts decline over time of physical
performance in elderly subjects [37]. In patients withTable 3 Linear regression for the association among hemoglo
6MWD test (m)
β SE p-value
Age −3.911 1.202 0.002
Sex −38.840 24.957 0.123
BMI −8.791 2.545 0.001
Smoking habits (pack/years) 4.452 22.221 0.842
CCI −3.988 7.412 0.592
CRP (mg/L) 0.859 0.862 0.322
FEV1%pred 1.731 0.558 0.003
Hb (g/dL) 24.108 8.693 0.007
CCI: Charlson Comorbidity Index; CRP: C-reactive Protein; 6MWD: six minutes walkin
Council; β: beta-coefficent.COPD, a low grade systemic inflammation, as well as
the inflammatory process in the lungs, has been dem-
onstrated [38]. It is tempting to speculate that this
process might play a role in the reduced exercise cap-
acity found in our patients. However, CRP was inversely
related to indices of exercise capacity in the bivariate
analysis (data not shown), but it was not associated
with the 6MWD or VO2max in the multivariate one,
when several potential confounders were taken into ac-
count. These results seem to indicate that inflammation is
not a main determinant of the reduced physical perform-
ance in COPD.
To the best of our knowledge, this is the first study dem-
onstrating that muscle strength, measured by quadriceps
and handgrip strength, were not related to hemoglobin
levels in COPD patients. Penninx et al. [16] found that
the strength of knee extensor and of handgrip was
lower in anemic than non anemic subjects [16], in non-
institutionalized elderly subjects from the general popula-
tion. The higher average age of the subjects in the study
carried out by Penninx et al. [16], and the different sample
selection, may justify the contrasting results.
As far as we know, only one study has investigated the
relationship between HRQL and anemia in COPD [19].
In a survey conducted on a sample extracted from the
general population and carried out by Krishnan et al.
[19], it was evident that anemia is associated with a
worse quality of life measured by the Short Form-36
(SF- 36) [19], in patients with moderate to severe COPD.
By using a specific instrument to measure quality of life
(SGRQ) in our study, we found an association between
anemia, activity, impact and total scores. It is possible
that a reduction in exercise capacity, related to a low
hemoglobin concentration, may adversely affect the
SGRQ activity score. It may also be hypothesized that
anemia produces fatigue through a reduced muscle
oxygenation, which in turn would lead to a decrease in
physical activity, and consequently to a deterioration of
psychosocial function.bin, exercise capacity and the degree of dyspnoea
VO2max (l/min) MRC dyspnoea scale
β SE p-value β SE p-value
−0.013 0.004 0.001 0.012 0.015 0.416
−0.467 0.080 <0.001 0.589 0.304 0.056
0.019 0.008 0.021 0.070 0.031 0.026
0.046 0.071 0.517 −0.056 0.271 0.837
−0.012 0.024 0.607 0.151 0.090 0.099
0.001 0.003 0.667 −0.010 0.011 0.365
0.004 0.002 0.019 −0.021 0.007 0.002
0.080 0.028 0.005 −0.104 0.106 0.328
g distance; VO2max: maximal oxygen consumption; MRC: Medical Research
Figure 3 Relationship between hemoglobin, six Minutes Walking Distance and St George Respiratory Questionnaire. Results of a multivariate
analysis of the relationship between hemoglobin (Hb) level and six Minutes Walking Distance (6MWD) (panel A) and the St George Respiratory
Questionnaire (SGRQ) total score (panel B). The predicted values of the 6MWT and SGRQ score were obtained by a regression model adjusted
for sex, age, Body Mass Index (BMI), smoking habits, FEV1, the Charlson’s Comorbidity Index and the serum concentration of C-reactive Protein.
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ation between hemoglobin levels, exercise capacity and
HRQL (Figure 3). These results indicate that an inde-
pendent determinant of exercise capacity and HRQL is
the hemoglobin concentration, even when it is not lower
than the cut-off indicating the presence of anemia. It
was evident from our data that a change of about two
grams in hemoglobin levels is associated with an in-
crease in the 6MWD distance of 50 meters, which is a
value perceived as significant by patients [39,40]. On the
other hand, the same variation of the concentrations of
hemoglobin is related to a reduction of 7 points SGRQ,
which corresponds to a mild to moderate improvement
of the quality of life [41]. These relationships could have
potential therapeutic implications, since physical per-
formance and quality of life could be improved, not only
by correcting the hemoglobin level in anemic subjects,
but also by increasing its concentrations in non-anemic
patients.Table 4 Linear regression for the association among hemoglo
activity, impact and total scores
SGRQ activity SGRQ impact SGR
β SE p-va
Age 0.302 0.250 0.231
Sex 10.565 5.415 0.054
BMI 1.092 0.548 0.05
Smoking habits (pack/years) −10.278 4.439 0.02
CCI −1.523 1.591 0.341
CRP (mg/L) 0.054 0.204 0.791
FEV1%pred −0.367 0.119 0.00
Hb (g/dL) −5.274 1.868 0.00
CCI: Charlson Comorbidity Index; CRP: C-reactive Protein.We emphasize that the linear relationship found in the
present study is valid only for hemoglobin values between
11 and 18 mg/dL, and extrapolation to lower or higher
concentrations (such as those found in severe anemia or
polycythemia) is not possible. We are aware that no infer-
ence is possible from our data and that prospective studies
and randomized controlled trials are warranted to test the
hypothesis. However, the result of the present study
support the findings of Silverberg et al. These authors
demonstrated, that the correction of anemia by erythro-
poietin was associated with an improvement in the quality
of life in hospitalized COPD patients [42].
Conclusion
In conclusion, anemia is a frequent condition in subjects
with COPD, although it seems to have a similar preva-
lence to that found in the general population. Even if we
could not establish a causality link, our data demonstrate
that anemia is associated with a reduction of exercisebin and St. George Respiratory Questionnaire (SGRQ)
Q total
lue β SE p-value β SE p-value
0.073 0.234 0.755 0.095 0.215 0.661
−1.419 5.074 0.780 2.341 4.659 0.617
0 −0.087 0.514 0.866 0.422 0.472 0.374
3 −3.880 4.160 0.354 −4.266 3.820 0.267
0.619 1.491 0.679 −0.218 1.369 0.874
0.208 0.191 0.279 0.188 0.175 0.287
3 −0.328 0.112 0.004 −0.352 0.103 0.001
6 −3.443 1.751 0.050 −3.783 1.608 0.021
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the quality of life. On the contrary anemia does not seem
related to muscle strength. Finally, the linear relationship
between hemoglobin levels, important indices of exercise
capacity, and quality of life, may provide support to
pharmacological interventions in order to improve the
poor health status and prognosis of patients with COPD.
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